So the positives:
-Mgmt finally got off their backsides and attempted to address the SP slide
-No imminent need for a CR
Negatives:
-Prices received well under guidance with some wishy washy explanation. We've heard this type of story before right...always some reason why guidance not met.
-Then this gem "Syrah remains optimistic that improved prices are achievable"...really is that it!! They either have forward contracts with better prices or not. No half way house here, that sounds suspiciously like they either are not getting new contracts or not actually getting better prices.
-Wow cost mgmt actions continuing! As a shareholder I want statements a little more definitive like "cost mgmt actions have resulted in C1 costs decreasing by $20/t with further improvements likely"
Overall, I'm glad they released this but am really over this b.s. flowery language used in every single announcement. I believe the lack of clarity in their statements is a big problem for LT holders and a gift for shorter and traders. Anyone else feel that way?
- Forums
- ASX - By Stock
- SYR
- Ann: Q1 2019 Interim Update
Ann: Q1 2019 Interim Update, page-42
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.3¢ |
Change
-0.003(1.11%) |
Mkt cap ! $232.8M |
Open | High | Low | Value | Volume |
22.5¢ | 23.0¢ | 21.5¢ | $545.5K | 2.503M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 247498 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 269427 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 116062 | 1.070 |
10 | 209299 | 1.065 |
8 | 106613 | 1.060 |
6 | 96647 | 1.055 |
10 | 132219 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 58078 | 4 |
1.080 | 70753 | 4 |
1.085 | 72117 | 5 |
1.090 | 103210 | 6 |
1.095 | 57928 | 2 |
Last trade - 11.19am 25/11/2024 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online